Literature DB >> 21547021

Radiotherapeutic Options for Symptom Control in Breast Cancer.

Birgitt van Oorschot1, Gabriele Beckmann, Wolfgang Schulze, Dirk Rades, Petra Feyer.   

Abstract

SUMMARY: The majority of breast cancer patients will require radiation therapy at some time during the course of their disease. An estimated 30-50% of all radiation treatments are of palliative nature, either to alleviate symptoms or prophylactic to prevent deterioration of quality of life due to locally progressive disease. Radiotherapy is a locally effective tool, and typically causes no systemic and mostly mild acute side effects. The following article provides an overview of options and decision-making in palliative radiotherapy for symptom control.

Entities:  

Year:  2011        PMID: 21547021      PMCID: PMC3083266          DOI: 10.1159/000324564

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  48 in total

1.  Presentation, management and outcome of axillary recurrence from breast cancer.

Authors:  L A Newman; K K Hunt; T Buchholz; H M Kuerer; G Vlastos; N Mirza; F C Ames; M I Ross; S E Singletary
Journal:  Am J Surg       Date:  2000-10       Impact factor: 2.565

2.  Radiation therapy of spinal cord compression caused by breast cancer: report of a prospective trial.

Authors:  E Maranzano; P Latini; F Checcaglini; E Perrucci; C Aristei; B M Panizza; S Ricci
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

3.  Prognostic indicators in metastatic spinal cord compression: using functional independence measure and Tokuhashi scale to optimize rehabilitation planning.

Authors:  V Tang; D Harvey; J Park Dorsay; S Jiang; M P Rathbone
Journal:  Spinal Cord       Date:  2007-01-16       Impact factor: 2.772

4.  A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.

Authors:  Paul W Sperduto; Brian Berkey; Laurie E Gaspar; Minesh Mehta; Walter Curran
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-10       Impact factor: 7.038

5.  Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases.

Authors:  Edward Chow; Lori Davis; Lori Holden; May Tsao; Cyril Danjoux
Journal:  J Pain Symptom Manage       Date:  2005-07       Impact factor: 3.612

6.  [Stereotactic irradiation of liver metastases].

Authors:  K K Herfarth; J Debus; F Lohr; M L Bahner; M Wannenmacher
Journal:  Radiologe       Date:  2001-01       Impact factor: 0.635

7.  Stereotactic radiotherapy of primary liver cancer and hepatic metastases.

Authors:  Joern Wulf; Matthias Guckenberger; Ulrich Haedinger; Ulrich Oppitz; Gerd Mueller; Kurt Baier; Michael Flentje
Journal:  Acta Oncol       Date:  2006       Impact factor: 4.089

8.  DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis.

Authors:  Petra Feyer; Marie-Luise Sautter-Bihl; Wilfried Budach; Jürgen Dunst; Wulf Haase; Wolfgang Harms; Felix Sedlmayer; Rainer Souchon; Frederik Wenz; Rolf Sauer
Journal:  Strahlenther Onkol       Date:  2010-01-26       Impact factor: 3.621

9.  The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma.

Authors:  Rose Lai; Chau T Dang; Mark G Malkin; Lauren E Abrey
Journal:  Cancer       Date:  2004-08-15       Impact factor: 6.860

10.  Quality of life in brain metastases radiation trials: a literature review.

Authors:  J Wong; A Hird; A Kirou-Mauro; J Napolskikh; E Chow
Journal:  Curr Oncol       Date:  2008-10       Impact factor: 3.677

View more
  1 in total

1.  Radiotherapy of Bone Metastasis in Breast Cancer Patients - Current Approaches.

Authors:  Petra C Feyer; Maria Steingraeber
Journal:  Breast Care (Basel)       Date:  2012-04-25       Impact factor: 2.860

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.